TArgeting Type 1 Diabetes Using POLyamines (TADPOL)
TArgeting Type 1 Diabetes Using POLyamines (TADPOL)
Active, not recruiting · NCT05594563 · Registry updated 2026-08-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| TArgeting Type 1 Diabetes Using POLyamines (TADPOL) | Nutritional and Metabolic Diseases, autoimmune disease, diabetes mellitus, endocrine system disorder, glucose metabolism disease, immune system disorder, metabolic disease, type 1 diabetes mellitus | Active, not recruiting | Phase 2 | 2026-08-21 | NCT05594563 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Cancer Prevention Pharmaceuticals, Inc. | 2 |
| Emily K. Sims | 1 |
| Juvenile Diabetes Research Foundation | 33 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Barbara Davis Center | Aurora | United States | 9 |
| Children's Mercy Hospital | Kansas City | United States | 3 |
| IU Health Riley Hospital for Children | Indianapolis | United States | 1 |
| Medical College of Wisconsin | Milwaukee | United States | 483 |
| MHealth Fairview Masonic Children's Hospital and Specialty Clinics | Minneapolis | United States | 1 |
| University of Chicago | Chicago | United States | 312 |
| University of Michigan | Ann Arbor | United States | 538 |